Significant Prognostic Impact of Chemoradiotherapy-Induced Hemoglobin Decrease on Treatment Outcomes of Nasopharyngeal Carcinoma
Journal of Cancer2015Vol. 6(6), pp. 502–510
Citations Over TimeTop 24% of 2015 papers
Xue-Xia Liang, Qun Li, Zhen Su, Xiao-Wen Lan, Pu‐Yun OuYang, Yan‐Ping Mao, D. Shi, Wuguo Deng, Zhi-Bin Cheng, Si-Yang Wang, Fang-Yun Xie
Abstract
Chemoradiotherapy-induced decreased Hb levels have negative influence on locoregional control and survival, and might counteract the benefit of neoadjuvant/concomitant chemotherapy. Further studies on supportive care to maintain sufficient Hb level during chemo-radiotherapy are warranted.
Related Papers
- → Hemolytic uremic syndrome in families ? an argentinian experience(1996)3 cited
- Quantitative detection of epstein-Barr virus infectious status in nasopharyngeal carcinoma tissues(2010)
- Correlation between Epstern-Barr virus andangiogenesis of patients with nasopharyngeal carcinoma(2011)
- Value Analysis of Plasma Epstein-barr Virus DNA Concentration Detection in Screening and Clinical Staging Diagnosis of Nasopharyngeal Carcinoma(2020)
- → Data from Multiparametric Detection of Antibodies against Different EBV Antigens to Predict Risk for Nasopharyngeal Carcinoma in a High-Risk Population of China(2023)